EUR 0.65
(3.17%)
Year | Revenue | Revenue Growth |
---|---|---|
2023 | 9826.00 EUR | -99.91% |
2022 | 10.4 Million EUR | 38.33% |
2021 | 7.52 Million EUR | 10.24% |
2020 | 6.82 Million EUR | 8.24% |
2019 | 6.3 Million EUR | 2.33% |
2018 | 6.16 Million EUR | 93106.78% |
2017 | 6611.33 EUR | 1.64% |
2016 | 6504.56 EUR | -9.91% |
2015 | 7220.07 EUR | -99.85% |
2014 | 4.73 Million EUR | 61.02% |
2013 | 2.93 Million EUR | 13.37% |
2012 | 2.59 Million EUR | 448.95% |
2011 | 472.33 Thousand EUR | 0.0% |
Year | Revenue | Revenue Growth |
---|---|---|
2024 Q2 | 4.55 Million EUR | 0.0% |
2023 Q2 | 4.87 Million EUR | 0.0% |
2023 FY | 9.82 Million EUR | -5.59% |
2023 Q4 | 4.95 Million EUR | 0.0% |
2022 Q4 | 5.19 Million EUR | 0.0% |
2022 FY | 10.4 Million EUR | 38.33% |
2022 Q2 | 5.21 Million EUR | 0.0% |
2021 FY | 7.52 Million EUR | 10.24% |
2021 Q4 | 3.92 Million EUR | 0.0% |
2021 Q2 | 3.6 Million EUR | 0.0% |
2020 Q2 | 3.35 Million EUR | 0.0% |
2020 FY | 6.82 Million EUR | 8.24% |
2020 Q4 | 3.47 Million EUR | 0.0% |
2019 Q4 | 3461.30 EUR | 0.0% |
2019 Q2 | 3544.00 EUR | 0.0% |
2019 FY | 6.3 Million EUR | 2.33% |
2018 Q2 | 2.94 Million EUR | 0.0% |
2018 Q4 | 3.22 Million EUR | 0.0% |
2018 FY | 6.16 Million EUR | 93106.78% |
2017 Q4 | 3502.70 EUR | 0.0% |
2017 FY | 6611.33 EUR | 1.64% |
2017 Q2 | 3108.63 EUR | 0.0% |
2016 FY | 6504.56 EUR | -9.91% |
2016 Q2 | 3190.60 EUR | 0.0% |
2016 Q4 | 3313.96 EUR | 0.0% |
2015 FY | 7220.07 EUR | -99.85% |
2015 Q2 | 3001.13 EUR | 0.0% |
2015 Q4 | 4218.94 EUR | 0.0% |
2014 Q1 | 1.27 Million EUR | 0.0% |
2014 Q2 | 1911.18 EUR | -99.85% |
2014 Q4 | 2852.77 EUR | -99.78% |
2014 FY | 4.73 Million EUR | 61.02% |
2014 Q3 | 1.27 Million EUR | 66376.16% |
2013 Q3 | 734.88 Thousand EUR | 0.0% |
2013 Q1 | 734.88 Thousand EUR | 0.0% |
2013 Q4 | 1.27 Million EUR | 72.88% |
2013 FY | 2.93 Million EUR | 13.37% |
2013 Q2 | 734.88 Thousand EUR | 0.0% |
2012 FY | 2.59 Million EUR | 448.95% |
2012 Q2 | 648.21 Thousand EUR | 0.0% |
2012 Q4 | 734.88 Thousand EUR | 13.37% |
2012 Q1 | 648.21 Thousand EUR | 0.0% |
2012 Q3 | 648.21 Thousand EUR | 0.0% |
2011 Q2 | 118.08 Thousand EUR | 0.0% |
2011 FY | 472.33 Thousand EUR | 0.0% |
2011 Q3 | 118.08 Thousand EUR | 0.0% |
2011 Q1 | 118.08 Thousand EUR | 0.0% |
2011 Q4 | 648.21 Thousand EUR | 448.95% |
2010 Q4 | 118.08 Thousand EUR | 0.0% |
Name | Revenue | Revenue Difference |
---|---|---|
Affluent Medical SA | 1.22 Million EUR | 99.197% |
Carmat SA | 2.84 Million EUR | 99.655% |
Diagnostic Medical Systems S.A. | 42.15 Million EUR | 99.977% |
Euromedis Groupe | 37.42 Million EUR | 99.974% |
Eurobio Scientific Société anonyme | 130.64 Million EUR | 99.992% |
Ikonisys S.A. | 448.55 Thousand EUR | 97.809% |
Implanet S.A. | 7.44 Million EUR | 99.868% |
Median Technologies SA | 22.22 Million EUR | 99.956% |
SpineGuard SA | 4.31 Million EUR | 99.772% |
Theraclion SA | 1.82 Million EUR | 99.461% |
Euroapi S.A. | 1.01 Billion EUR | 99.999% |
Guerbet SA | 785.69 Million EUR | 99.999% |